A chemoimmunotherapy regimen consisting of rituximab, ifosfamide, carboplatin and etoposide used to treat indolent and aggressive forms of non-Hodgkin lymphoma; also used to treat relapsed and refractory non-Hodgkin lymphoma. Or An abbreviation for a chemotherapy combination used to treat certain types of non-Hodgkin lymphoma. It includes the drugs rituximab, ifosfamide, carboplatin, and etoposide phosphate. Also called R-ICE.